Alterations of XIST (X-Inactive Specific Transcript), originally described as an X-linked gene involved in X-chromosomal inactivation, have been documented in HPV-independent cervical cancer, where it represses PTEN and TP53, resulting in enhanced resistance to therapy [79]. This evidence concerns the gene XIST and cervical carcinoma.